Regarding BRAF-inhibitor Therapy of Primary Ameloblastoma

Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology - United States
doi 10.1016/j.oooo.2016.04.020
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

EGFR Activation Constitutes an Adaptive Response to BRAF Inhibitor Therapy

Cancer Discovery
Oncology
2014English

Increased Risk of Radiation Necrosis Following BRAF Inhibitor Therapy and Stereotactic Radiosurgery (SRS)

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2016English

Ineffective Anti PD-1 Therapy After BRAF Inhibitor Failure in Advanced Melanoma

BMC Cancer
Cancer ResearchOncologyGenetics
2018English

BRAF-Inhibitor Auch Langfristig Effektiv

Im Focus Onkologie
2012English

BRAF Inhibitor Therapy for Melanoma, Thyroid and Colorectal Cancers: Development of Resistance and Future Prospects

Current Cancer Drug Targets
Cancer ResearchDrug DiscoveryOncologyPharmacology
2014English

Expression of BRAF, EGFR and CD10 in Ameloblastoma: Their Potential Role in Local Tumour Invasiveness

International Journal of Oral and Maxillofacial Surgery
OtorhinolaryngologyOral SurgerySurgery
2017English

Combination Therapy Targeting the Elevated Interleukin-6 Level Reduces Invasive Migration of BRAF Inhibitor-Resistant Melanoma Cells

Molecular Oncology
Cancer ResearchMedicineOncologyGeneticsMolecular Medicine
2019English

Efficacy, Safety, and Tolerability of Approved Combination BRAF and MEK Inhibitor Regimens for BRAF-Mutant Melanoma

Cancers
Cancer ResearchOncology
2019English

Primary Sinonasal Ameloblastoma - A Rare Cause of Unilateral Nasal Obstruction

Srpski Arhiv Za Celokupno Lekarstvo
Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy